Editing Melatonin

Jump to: navigation, search

Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.

The edit can be undone. Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision Your text
Line 1: Line 1:
 
[[Information on nutritional supplements people with ALS have been taking]]
 
[[Information on nutritional supplements people with ALS have been taking]]
 +
  
 
In animals, melatonin, N-acetyl-5-methoxy tryptamine, is a hormone produced and secreted by the pineal gland. It is involved in the synchronization of the circadian rhythms of e.g. sleep and blood pressure.  
 
In animals, melatonin, N-acetyl-5-methoxy tryptamine, is a hormone produced and secreted by the pineal gland. It is involved in the synchronization of the circadian rhythms of e.g. sleep and blood pressure.  
Line 11: Line 12:
 
== Effects on ALS ==
 
== Effects on ALS ==
  
In ALS, the most promising effects of melatonin are those of blocking apoptotic pathways and reducing oxidative damage caused by free radicals by scavenging. The mechanisms of melatonin antiapoptotic effects are not completely clear, although the mitochondria have been identified as its target. {{#pmid: 26295035|dePaula2015}},{{#pmid: 17014688|Weishaupt2006}}
+
In ALS, the most promising effects of melatonin are those of blocking apoptotic pathways and reducing oxidative damage caused by free radicals by scavenging. The mechanisms of melatonin antiapoptotic effects are not completely clear, although the mitochondria have been identified as its target. [1],[2]
  
 
''Melatonin is a molecule with numerous properties applicable to the treatment of neurological diseases. Among these properties are the following: potent scavenger of oxygen and nitrogen reactive species, anti-inflammatory features, immuno-enhancing nature, and modulation of circadian rhythmicity.'' {{#pmid:28721826|revilla2017}}
 
''Melatonin is a molecule with numerous properties applicable to the treatment of neurological diseases. Among these properties are the following: potent scavenger of oxygen and nitrogen reactive species, anti-inflammatory features, immuno-enhancing nature, and modulation of circadian rhythmicity.'' {{#pmid:28721826|revilla2017}}
Line 17: Line 18:
 
== Cautions ==
 
== Cautions ==
  
Can cause some side effects including headache, short-term feelings of depression, daytime sleepiness, dizziness, stomach cramps, and irritability. Do not drive or use machinery for four to five hours after taking melatonin. (Source: [http://www.webmd.com/vitamins-supplements/ingredientmono-940-melatonin.aspx?activeingredientid=940 WebMD]) Can cause reduced blood flow and hypothermia (in the elderly). In auto-immune disorders, it is unclear whether melatonin may either ameliorate or exacerbate symptoms due to immunomodulation. Can lower FSH levels, and effects on human reproduction remain unclear. Anticoagulants and other substances are known to interact with melatonin. (Source: [https://en.wikipedia.org/wiki/Melatonin Wikipedia])
+
Can cause some side effects including headache, short-term feelings of depression, daytime sleepiness, dizziness, stomach cramps, and irritability. Do not drive or use machinery for four to five hours after taking melatonin. (Source: [http://www.webmd.com/vitamins-supplements/ingredientmono-940-melatonin.aspx?activeingredientid=940 WebMD]) Can cause reduced blood flow and hypothermia (in the elderly). In auto-immune disorders, it is unclear whether melatonin may either ameliorate or exacerbate symptoms due to immunomodulation. Melatonin can lower FSH levels, and its effects on human reproduction remain unclear. Anticoagulants and other substances are known to interact with melatonin. (Source: [https://en.wikipedia.org/wiki/Melatonin Wikipedia])
  
 
== Research article link collection ==
 
== Research article link collection ==
Line 24: Line 25:
  
 
== References ==
 
== References ==
 +
 +
[1] de Paula, C. Z., Gonçalves, B. D. C., & Vieira, L. B. (2015). An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington’s Disease. BioMed Research International. [http://dx.doi.org/10.1155/2015/198612]
 +
 +
[2] Weishaupt JH, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén AL, Hardeland R, Bähr M, Nave KA, Ehrenreich H (2006). Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res., 41(4), 313–23. [http://www.ncbi.nlm.nih.gov/pubmed/17014688]
  
 
[[Category:Supplement data pages]]
 
[[Category:Supplement data pages]]

Please note that all contributions to MyWiki may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see MyWiki:Copyrights for details). Do not submit copyrighted work without permission!

To protect the wiki against automated edit spam, we kindly ask you to solve the following CAPTCHA:

Cancel | Editing help (opens in new window)

Template used on this page: